Astera Labs (NASDAQ:ALAB) Shares Down 19.2% Following Analyst Downgrade

Key Points

• Astera Labs shares fell 19.2% to about $180 after TD Cowen cut its price target from $300 to $225 and maintained a Hold rating.
• The company posted a strong third quarter: revenue rose 154% year over year to $584.9 million, and EPS of $1.32 beat the $1.19 consensus. Management forecast fourth-quarter revenue of $730 million to $750 million.
• Analyst opinions remain divided, and concerns about the stock’s rich valuation, competition, customer concentration and rising costs persist despite the earnings beat.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) dropped 19.2% on Thursday after TD Cowen lowered their price target on the stock from $300.00 to $225.00. TD Cowen currently has a hold rating on the stock. Astera Labs traded as low as $180.11 and last traded at $180.4430. 3,260,599 shares changed hands during mid-day trading, a decline of 36% from the average daily volume of 5,100,226 shares. The stock had previously closed at $223.27.

Several other equities research analysts have also commented on the stock. Northland Securities upgraded shares of Astera Labs from a "market perform" rating to an "outperform" rating and set a $315.00 price objective on the stock in a research report on Wednesday. Jefferies Financial Group upped their price target on shares of Astera Labs from $270.00 to $450.00 and gave the company a "buy" rating in a report on Wednesday, August 5th. Citigroup lowered shares of Astera Labs from a "buy" rating to a "hold" rating in a research report on Friday, October 9th. Zacks Research cut shares of Astera Labs from a "strong-buy" rating to a "hold" rating in a research note on Monday, October 5th. Finally, Susquehanna cut their price objective on Astera Labs from $310.00 to $258.00 and set a "neutral" rating for the company in a research report on Wednesday. Thirteen equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to data from MarketBeat, Astera Labs currently has an average rating of "Moderate Buy" and an average price target of $320.85.

Insider Buying and Selling at Astera Labs

In other news, General Counsel Philip Mazzara sold 6,801 shares of the business's stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.50, for a total value of $2,315,740.50. Following the completion of the transaction, the general counsel owned 96,542 shares of the company's stock, valued at $32,872,551. The trade was a 6.58% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan Dyckerhoff sold 8,994 shares of the company's stock in a transaction that occurred on Wednesday, October 7th. The shares were sold at an average price of $376.06, for a total transaction of $3,382,283.64. Following the transaction, the director directly owned 2,648 shares in the company, valued at $995,806.88. The trade was a 77.25% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 396,059 shares of company stock valued at $123,408,470. Corporate insiders own 10.40% of the company's stock.

Astera Labs News Summary

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Astera reported Q3 revenue of $584.9 million, up 154% year over year, and EPS of $1.32 versus the $1.19 consensus. Scorpio fabric switches were the largest product family, supporting the strong results. Management forecast Q4 revenue of $730 million to $750 million and pointed to opportunities in optical connectivity, memory and rack-scale AI. Astera Labs Q3 results
• Positive Sentiment: BMO Capital Markets initiated coverage with an Outperform rating and a $375 price target. Northland Securities also upgraded ALAB to Outperform, with a $315 target. BMO rating Northland rating
• Neutral Sentiment: Analyst views are divided. Morgan Stanley raised its target to $389 and RBC maintained Outperform while cutting its target to $400; TD Cowen and Susquehanna lowered targets, with Hold and Neutral ratings, respectively.
• Negative Sentiment: The earnings beat has not overcome concern that ALAB’s valuation remains rich. Coverage also cites competitive threats, customer concentration and rising costs as risks; some analysts have cut forecasts after the results. ALAB valuation concerns

Institutional Investors Weigh In On Astera Labs

Hedge funds have recently made changes to their positions in the business. BlackRock Inc. bought a new stake in shares of Astera Labs during the 2nd quarter worth about $6,609,581,000. Atreides Management LP boosted its holdings in shares of Astera Labs by 108.9% in the first quarter. Atreides Management LP now owns 3,365,787 shares of the company's stock valued at $368,890,000 after acquiring an additional 1,754,593 shares in the last quarter. Van ECK Associates Corp boosted its holdings in shares of Astera Labs by 20.0% in the second quarter. Van ECK Associates Corp now owns 2,237,961 shares of the company's stock valued at $1,080,980,000 after acquiring an additional 373,545 shares in the last quarter. Bank of America Corp DE acquired a new position in shares of Astera Labs during the second quarter valued at approximately $1,061,791,000. Finally, Amundi increased its stake in shares of Astera Labs by 77.9% during the first quarter. Amundi now owns 1,880,830 shares of the company's stock valued at $206,139,000 after acquiring an additional 823,477 shares during the period. Institutional investors and hedge funds own 60.47% of the company's stock.

Astera Labs Price Performance

The stock has a market cap of $32.83 billion, a P/E ratio of 73.31 and a beta of 3.85. The company has a fifty day moving average of $304.94 and a 200 day moving average of $255.78.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its earnings results on Tuesday, November 3rd. The company reported $1.32 earnings per share for the quarter, topping analysts' consensus estimates of $1.19 by $0.13. The firm had revenue of $584.90 million during the quarter, compared to the consensus estimate of $550.78 million. Astera Labs had a return on equity of 27.30% and a net margin of 29.64%. The firm's revenue for the quarter was up 153.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.49 earnings per share. As a group, analysts anticipate that Astera Labs, Inc. will post 2.71 EPS for the current year.

Astera Labs Company Profile

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company's portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.